NCT06171425 is a clinical trial in Diffuse Parenchymal Lung Disease, sponsored by Hacettepe University.

Who is sponsoring NCT06171425?

NCT06171425 is sponsored by Hacettepe University.

What condition does NCT06171425 study?

NCT06171425 studies Diffuse Parenchymal Lung Disease, Frailty, Physical Inactivity.

Is NCT06171425 still recruiting?

NCT06171425 is currently status unknown. Last updated 19 December 2023.

Last reviewed 2023-12-19 · How we verify

NCT06171425

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

Status unknown Last updated 19 December 2023

What this trial tests

trial in Diffuse Parenchymal Lung Disease in 28 participants. Status unknown.

Timeline

25 December 2023

Primary endpoint
1 January 2024

22 February 2024

Quick facts

Lead sponsor	Hacettepe University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	28
Start date	25 December 2023
Primary completion	1 January 2024
Estimated completion	22 February 2024
Sites	1 location across Turkey (Türkiye)

Conditions studied

Diffuse Parenchymal Lung Disease — all drugs for Diffuse Parenchymal Lung Disease →
Frailty — all drugs for Frailty →
Physical Inactivity — all drugs for Physical Inactivity →

Sponsor

Hacettepe University

Who can join

Adults 30 to 65, any sex, with Diffuse Parenchymal Lung Disease or Frailty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06171425 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 19 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing